OptimizeRx Corporation

NasdaqCM:OPRX Stock Report

Market Cap: US$81.4m

OptimizeRx Balance Sheet Health

Financial Health criteria checks 5/6

OptimizeRx has a total shareholder equity of $114.5M and total debt of $35.3M, which brings its debt-to-equity ratio to 30.8%. Its total assets and total liabilities are $165.2M and $50.7M respectively.

Key information

30.8%

Debt to equity ratio

US$35.28m

Debt

Interest coverage ration/a
CashUS$16.13m
EquityUS$114.47m
Total liabilitiesUS$50.73m
Total assetsUS$165.20m

Recent financial health updates

Recent updates

Does OptimizeRx (NASDAQ:OPRX) Have A Healthy Balance Sheet?

Nov 16
Does OptimizeRx (NASDAQ:OPRX) Have A Healthy Balance Sheet?

OptimizeRx (NASDAQ:OPRX) Is Carrying A Fair Bit Of Debt

Jul 30
OptimizeRx (NASDAQ:OPRX) Is Carrying A Fair Bit Of Debt

OptimizeRx Corporation's (NASDAQ:OPRX) 36% Jump Shows Its Popularity With Investors

Jan 09
OptimizeRx Corporation's (NASDAQ:OPRX) 36% Jump Shows Its Popularity With Investors

Analyst Forecasts Just Became More Bearish On OptimizeRx Corporation (NASDAQ:OPRX)

Aug 24
Analyst Forecasts Just Became More Bearish On OptimizeRx Corporation (NASDAQ:OPRX)

OptimizeRx Corporation (NASDAQ:OPRX) Shares May Have Slumped 38% But Getting In Cheap Is Still Unlikely

Aug 16
OptimizeRx Corporation (NASDAQ:OPRX) Shares May Have Slumped 38% But Getting In Cheap Is Still Unlikely

Is Now An Opportune Moment To Examine OptimizeRx Corporation (NASDAQ:OPRX)?

May 31
Is Now An Opportune Moment To Examine OptimizeRx Corporation (NASDAQ:OPRX)?

OptimizeRx: A Top Candidate For My Speculative 'Bio Boom' Portfolio

Oct 12

Is Now The Time To Look At Buying OptimizeRx Corporation (NASDAQ:OPRX)?

Sep 23
Is Now The Time To Look At Buying OptimizeRx Corporation (NASDAQ:OPRX)?

OptimizeRx extends reach with Cooler Screens Partnership

Jul 26

OptimizeRx: A Small-Cap Digital Health Technology Gem With Near-Term Inflection In Profitability

Jun 27

The Strong Earnings Posted By OptimizeRx (NASDAQ:OPRX) Are A Good Indication Of The Strength Of The Business

Nov 16
The Strong Earnings Posted By OptimizeRx (NASDAQ:OPRX) Are A Good Indication Of The Strength Of The Business

Why We Think OptimizeRx Corporation's (NASDAQ:OPRX) CEO Compensation Is Not Excessive At All

Aug 13
Why We Think OptimizeRx Corporation's (NASDAQ:OPRX) CEO Compensation Is Not Excessive At All

A Look At The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX)

Jul 15
A Look At The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX)

Here's Why We're Not At All Concerned With OptimizeRx's (NASDAQ:OPRX) Cash Burn Situation

Jun 24
Here's Why We're Not At All Concerned With OptimizeRx's (NASDAQ:OPRX) Cash Burn Situation

Investors Will Want OptimizeRx's (NASDAQ:OPRX) Growth In ROCE To Persist

May 10
Investors Will Want OptimizeRx's (NASDAQ:OPRX) Growth In ROCE To Persist

Financial Position Analysis

Short Term Liabilities: OPRX's short term assets ($46.9M) exceed its short term liabilities ($14.5M).

Long Term Liabilities: OPRX's short term assets ($46.9M) exceed its long term liabilities ($36.2M).


Debt to Equity History and Analysis

Debt Level: OPRX's net debt to equity ratio (16.7%) is considered satisfactory.

Reducing Debt: OPRX's debt to equity ratio has increased from 0% to 30.8% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: OPRX has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: OPRX has sufficient cash runway for 2.5 years if free cash flow continues to grow at historical rates of 7.8% each year.


Discover healthy companies